Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Technology Insight: high-intensity focused ultrasound for urologic cancers

Abstract

The growing interest in high-intensity focused ultrasound (HIFU) technology is mainly due to its many potential applications as a minimally invasive therapy. It has been introduced to urologic oncology as a treatment for prostate and kidney cancers. While its application in the kidney is still at the clinical feasibility phase, HIFU technology is currently used in daily practice in Europe for the treatment of prostate cancer. Literature describing the results of HIFU for prostate cancer is mainly based on several series of patients from clinical development teams. The latest published results suggest that HIFU treatment is a valuable option for well-differentiated and moderately-differentiated tumors, as well as for local recurrence after external-beam radiation therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Blana A et al. (2004) High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urol 63: 297–300

    Article  Google Scholar 

  2. Poissonnier L et al. (2003) Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA<or +10 ng/ml). Prog Urol 13: 60–72

    PubMed  Google Scholar 

  3. Lynn JG and Putman TJ (1944) Histological and cerebral lesions produced by focused ultrasound. Am J Pathol 20: 637–649

    CAS  PubMed  PubMed Central  Google Scholar 

  4. ter Haar G (2000) Intervention and therapy. Ultrasound Med Biol 23 (Suppl 1): S51–S54

    Article  Google Scholar 

  5. Chapelon JY et al. (1992) Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 22: 147–152

    Article  CAS  Google Scholar 

  6. Uchida T et al. (2002) Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology 59: 394–398

    Article  Google Scholar 

  7. Chapelon JY et al. (2000) New piezoelectric transducers for therapeutic ultrasound. Ultrasound Med Biol 26: 153–159

    Article  CAS  Google Scholar 

  8. Curiel L et al. (2002) 1.5-D high intensity focused ultrasound array for non-invasive prostate cancer surgery. IEEE Trans Ultrason Ferroelectr Freq Control 49: 231–242

    Article  CAS  Google Scholar 

  9. Tan JS et al. (2000) Design of focused ultrasound phased arrays for prostate treatment, Ultrasonics Symp Proc IEEE 2: 1247–1251

    Google Scholar 

  10. Chavrier F et al. (2000) Modeling of high intensity focused ultrasound-induced lesions in the presence of cavitation bubbles. J Acoust Soc Am 108: 432–440

    Article  CAS  Google Scholar 

  11. Damianou CA et al. (1995) Evaluation of accuracy of a theoretical model for predicting the necrosed tissue volume during focused utrasound surgery. IEEE Trans Ultrason Ferroelec Freq Control 42: 182–187

    Article  Google Scholar 

  12. Curiel L et al. (2004) Experimental evaluation of lesion prediction modelling in the presence of cavitation bubbles: intended for high-intensity focused ultrasound prostate treatment Med Biol Eng Comput 42: 44–54

    Article  CAS  Google Scholar 

  13. Hynynen K et al. (1996) A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. Radiographics 16: 185–195

    Article  CAS  Google Scholar 

  14. Damianou C et al. (2004) High intensity focused ultrasound ablation of kidney guided by MRI. Ultrasound Med Biol 30: 397–404

    Article  Google Scholar 

  15. Wu T et al. (2001) Assessment of thermal tissue ablation with MR elastography. Magn Reson Med 45: 80–87

    Article  CAS  Google Scholar 

  16. Vaezy S et al. (2001) Real-time visualization of high-intensity focused ultrasound treatment using ultrasound imaging. Ultrasound Med Biol 27: 33–42

    Article  CAS  Google Scholar 

  17. Souchon R et al. (2003) Visualisation of HIFU lesions using elastography of the human prostate in vivo: preliminary results. Ultrasound Med Biol 29: 1007–1015

    Article  Google Scholar 

  18. Sedelaar JPM et al. (2000): The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol 37: 559–568

    Article  CAS  Google Scholar 

  19. Lu J et al. (1996) In vitro measurement of speed of sound during coagulate tissue heating. Ultrasonics Symp Proc IEEE 2: 1299–1302

    Google Scholar 

  20. Kishi M et al. (1975) Experimental studies of effects of intense ultrasound on implantable murine glioma. In: Proceedings of the 2nd European Congress on Ultrasonics in Medicine: 28–33 (Eds. Kazmer E et al.) Amsterdam: Excerpta Medica

    Google Scholar 

  21. Fry FJ and Johnson LK (1978) Tumour irradiation with intense ultrasound. Ultrasound Med Biol 4: 337–341

    Article  CAS  Google Scholar 

  22. Moore WE et al. (1989) Evaluation of high-intensity therapeutic ultrasound irradiation in the treatment of experimental hepatoma. J Pediatr Surg 24: 30–33

    Article  CAS  Google Scholar 

  23. Yang R et al. (1991) High-intensity focused ultrasound in the treatment of experimental liver cancer. Arch Surg 126: 1010–1010

    Article  Google Scholar 

  24. Chapelon JY et al. (1992) In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 52: 6353–6357

    CAS  PubMed  Google Scholar 

  25. Oosterhof GO et al. (1997) Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol 32: 91–95

    CAS  PubMed  Google Scholar 

  26. Adams JB et al. (1996) High-intensity focused ultrasound ablation of rabbit kidney tumors. J Endourol 10: 71–75

    Article  CAS  Google Scholar 

  27. Watkin NA et al. (1997) High-intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol 11: 191–196

    Article  CAS  Google Scholar 

  28. Kohrmann KU et al. (2002) Technical characterization of an ultrasound source for noninvasive thermoablation by high-intensity focused ultrasound. BJU Int 90: 248–252

    Article  CAS  Google Scholar 

  29. Damianou C (2003) In vitro and in vivo ablation of porcine renal tissues using high-intensity focused ultrasound. Ultrasound Med Biol 29: 1321–1330

    Article  Google Scholar 

  30. Foster RS et al. (1993) Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound. Eur Urol 23: 330–336

    Article  CAS  Google Scholar 

  31. Gelet A et al. (1993) Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 7: 249–253

    Article  CAS  Google Scholar 

  32. Vallancien G et al. (1991) Focused extracorporeal pyrotherapy: experimental results. Eur Urol 20: 211–219

    Article  CAS  Google Scholar 

  33. Vallancien G et al. (1993) Focused extracorporeal pyrotherapy: experimental study and feasibility in man. Semin Urol 11: 7–9

    CAS  PubMed  Google Scholar 

  34. Kohrmann KU et al. (2002) High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol 167: 2397–2403

    Article  Google Scholar 

  35. Wu F et al. (2003) Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. J Urol 170 (Pt 1): 2237–2240

    Article  Google Scholar 

  36. Vallancien G et al. (2004) Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 171 (Pt 1): 2265–2267

    Article  Google Scholar 

  37. Sanghvi NT et al. (2003) High-intensity focused ultrasound (HIFU) treatment of BPH: results of a multicenter phase III study. Ultrasound Med Biol 29: S102.

    Google Scholar 

  38. Thüroff S et al. (2003) High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17: 673–677

    Article  Google Scholar 

  39. Rebillard X et al. (2003) Treatment by HIFU of prostate cancer: survey of literature and treatment indications. Prog Urol 13: 1428–1456

    PubMed  Google Scholar 

  40. Beerlage HP et al. (1999) High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate 39: 41–46

    Article  CAS  Google Scholar 

  41. Rouviere O et al. (2001) MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 40: 265–274

    Article  CAS  Google Scholar 

  42. Chaussy C and Thüroff S (2003) The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 4: 248–252

    Article  Google Scholar 

  43. Chaussy CG and Thüroff S (2000) High-intensive focused ultrasound in localized prostate cancer. J Endourol 14: 293–299

    Article  CAS  Google Scholar 

  44. Thüroff S and Chaussy C (2000) High-intensity focused ultrasound: complications and adverse events. Mol Urol 4: 183–187

    PubMed  Google Scholar 

  45. Gelet A et al. (2004) Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urol 63: 625–629

    Article  Google Scholar 

  46. Kupelian PA et al. (2002) Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol 20: 3376–3385

    Article  Google Scholar 

  47. Kuban DA et al. (2003) Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57: 915–928

    Article  Google Scholar 

  48. Potters L et al. (2004) Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71: 29–33

    Article  Google Scholar 

  49. Dearnaley DP et al. (2005) Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92: 488–498

    Article  CAS  Google Scholar 

  50. Touma NJ et al. (2005) Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 173: 373–379

    Article  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge Jean-Yves Chapelon PhD and Laura Curiel PhD from the INSERM U556 for their assistance in the description of technological aspects of HIFU.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Chaussy.

Ethics declarations

Competing interests

Albert Gelet is a Clinical Investigator for the Ablatherm® device (EDAP TMS SA, Vaulx-en-Velin, France) and has received support from EDAP TMS SA to attend symposia.

Glossary

CAVITATION

Formation, growth and implosive collapse of bubbles in a liquid irradiated with high-intensity ultrasound resulting in intense local heating

ABSORPTION COEFFICIENT

A measure of the acoustic energy converted into heat in the tissues

THERMAL DOSE

Equivalent time in seconds for an exposure at a reference temperature of 43°C

SONICATON PARAMETERS

Physical properties whose values determine the behavior of the sound wave applied to tissues

OPERATING FREQUENCY

Number of complete oscillations per second of the sound wave generated by the transducer

PIEZOELECTRIC MATERIALS

Crystals that suffer a mechanical deformation when subjected to an electric potential

POWER DENSITY

Power per unit area normal to the direction of propagation

ACOUSTIC INTENSITY

The mean acoustic power transmitted through a unit area

DURATION of EXPOSURE

Time during which the sound wave is applied to the tissues at each burst of high-intensity focused ultrasound

ON/OFF RATIO

Quotient of exposure duration and waiting time between bursts of high-intensity focused ultrasound

DUNNING R3327

Experimental model of adenocarcinoma of the prostate in Copenhagen rats

AT2, AT6

Hormone-independent sublines of Dunning R3327

NADIR PSA

Lowest level of prostate-specific antigen achieved after treatment

GLEASON SCORE

Sum of grades assigned to the two largest cancerous areas of tissue samples; grades range from 1 (least aggressive) to 5 (most aggressive)

STRESS INCONTINENCE

Impaired urethral sphincter function leads to involuntary leakage of urine during physical exertion with increased intra-abdominal pressure

RESECTION CHIPS

Small prostate tissue pieces resulting from transurethral resection of the prostate

SECONDARY INFRAVESICAL OBSTRUCTION

Strictures of the bladder neck or of the urethra after a prostate treatment procedure

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaussy, C., Thüroff, S., Rebillard, X. et al. Technology Insight: high-intensity focused ultrasound for urologic cancers. Nat Rev Urol 2, 191–198 (2005). https://doi.org/10.1038/ncpuro0150

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0150

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing